A | B | C | D | E | F | G | H | I | |
---|---|---|---|---|---|---|---|---|---|
1 | TARGET AUDIENCE Industry: MIXED Job Titles: Head of R&D, Head of IP Geography: WORLDWIDE | ||||||||
2 | |||||||||
3 | Sr. No. | COMPANY | WEBSITE | FIRST NAME | LAST NAME | JOB TITLE | DONE BY | ||
4 | 1 | Energizer Holdings | https://www.energizerholdings.com/ | Emily | Riley | R&D Director | https://www.linkedin.com/in/emilyariley/ | emily.riley@energizer.com | NALTYX |
5 | 2 | CTRL-labs | https://www.ctrl-labs.com/ | Tarin | Ziyaee | Director R&D | https://www.linkedin.com/in/tarinziyaee/ | tarin@ctrl-labs.com | NALTYX |
6 | 3 | Ascensia Diabetes Care | https://www.ascensia.com/ | Kripa | Gaonkar | Director,Data and Digital Products Group, Global R&D | https://www.linkedin.com/in/kripa-gaonkar-b846653/ | kripa.gaonkar@ascensia.com | NALTYX |
7 | 4 | Avioq, Inc. | https://www.avioq.com/ | Don | Lockwood | Director, R&D | https://www.linkedin.com/in/don-lockwood-9815375/ | dlockwood@avioq.com | NALTYX |
8 | 5 | Edwards Lifesciences | https://www.edwards.com/ | Phil | Dang | Director, R&D | https://www.linkedin.com/in/phil-dang-03120918/ | phil_dang@edwards.com | NALTYX |
9 | 6 | Disney ABC Television Group | https://disneyabc.tv/ | Anthony | Accardo | Director R&D | https://www.linkedin.com/in/aaccardo/ | anthony.accardo@disney.com | NALTYX |
10 | 7 | Medtronic | https://www.medtronic.com/us-en/index.html | David | Racenet | VP R&D | https://www.linkedin.com/in/david-racenet-5a61268/ | david.racenet@medtronic.com | NALTYX |
11 | 8 | Vyaire Medical | https://www.vyaire.com/ | Blaine | Murakami | Director, R&D | https://www.linkedin.com/in/blainemurakami/ | bmurakami@vyaire.com | NALTYX |
12 | 9 | The Clorox Company | https://www.thecloroxcompany.com/ | Dane | Dickson | R&D Director | https://www.linkedin.com/in/dane-dickson-9285805/ | dane.dickson@clorox.com | NALTYX |
13 | 10 | DePuy Synthes Companies of Johnson & Johnson | https://www.depuysynthes.com/ | Joe | Ritz | Director of R&D | https://www.linkedin.com/in/joe-ritz-270335b/ | jritz@bme-tx.com | NALTYX |
14 | 11 | Cardinal Health | https://www.cardinalhealth.com/en.html | Jim | Theodorou | Director R&D | https://www.linkedin.com/in/ebrahim-shafizadeh-b6b3716 | ebrahim.shafizadeh@haemonetics.com | NALTYX |
15 | 12 | STERIS Corporation | https://www.steris.com/ | Josh | Tarrant | Director of R&D | https://www.linkedin.com/in/josh-tarrant-86063035/ | jtarrant@steris.com | NALTYX |
16 | 13 | Corindus Vascular Robotics | https://www.corindus.com/ | Per | Bergman | VP of R&D | https://www.linkedin.com/in/per-bergman-26396a2 | per.bergman@corindus.com | NALTYX |
17 | 14 | Stryker | https://www.stryker.com/ | Raj | Tiwari | Director, R&D | https://www.linkedin.com/in/raj-tiwari-0631994/ | raj.tiwari@stryker.com | NALTYX |
18 | 15 | Downs Food Group | http://www.downsfoodgroup.com/ | Brian | Carter | R&D Director | https://www.linkedin.com/in/brian-carter-8b786ab/ | bcarter@downsfoodgroup.com | NALTYX |
19 | 16 | Aridis Pharmaceutical | https://aridispharma.com/ | Jennifer | Woo | Director R&D | https://www.linkedin.com/in/jenniferclwoo/ | jwoo@aridispharma.com | NALTYX |
20 | 17 | Adhezion Biomedical, LLC | https://adhezion.com/ | Sheng | Zhang | VP of R&D | https://www.linkedin.com/in/sheng-zhang-b053a638/ | szhang@adhezion.com | NALTYX |
21 | 18 | Mars Petcare | https://www.mars.com/ | Laura | Paluch | R&D Director- Dry GIC Innovation Center | https://www.linkedin.com/in/laura-paluch-2a07631 | laura.paluch@effem.com | NALTYX |
22 | 19 | Medtronic | https://www.medtronic.com/us-en/index.html | Fred | Pelton | Senior Director, R&D | https://www.linkedin.com/in/fred-pelton-53302b7/ | fred.pelton@medtronic.com | NALTYX |
23 | 20 | Cardinal Health | https://www.cardinalhealth.com/en.html | Rork | Swisher | VP Product Development (R&D) | https://www.linkedin.com/in/rork-swisher-pmp-dfss-black-belt-8a55428/ | rork.swisher@cardinalhealth.com | NALTYX |
24 | 21 | Campbell Soup Company | https://www.campbellsoupcompany.com/ | Menexia | Tsoubeli | Vice President R&D | https://www.linkedin.com/in/menexia-tsoubeli-37566b8/ | menexia_tsoubeli@campbellsoup.com | NALTYX |
25 | 22 | Bemis Company, Inc. | http://www.bemis.com/ | Otacilio | Berbert | Sr. R&D Fellow | https://www.linkedin.com/in/otacilio-berbert-62156512/ | oberbert@bemis.com | NALTYX |
26 | 23 | Edgewell Personal Care | http://edgewell.com/ | Brian | King | R&D Program Director - MBA & PMP | https://www.linkedin.com/in/brian-king-2b96448/ | brian.king@edgewell.com | NALTYX |
27 | 24 | Elucent Medical, Inc. | https://elucentmedical.com/ | Jason | Hiltner | VP of R&D | https://www.linkedin.com/in/jason-hiltner-50348316 | jason.hiltner@elucent.com | NALTYX |
28 | 25 | Every Man Jack | https://everymanjack.com/ | Heather | Halpern | R&D/Product Development | https://www.linkedin.com/in/heather-halpern-4689a8a/ | heather@kissmyface.com | NALTYX |
29 | 26 | Dow Chemical Company | https://www.dow.com/en-us | Marty | Degroot | R&D Director | https://www.linkedin.com/in/marty-degroot-3ab89515/ | mdegroot@dow.com | NALTYX |
30 | 27 | Novelion Therapeutics | https://www.novelion.com/ | Murray | Stewart | Head of R&D | https://www.linkedin.com/in/murray-stewart-90704b5/ | mstewart@rhythmtx.com | NALTYX |
31 | 28 | Traditional Medicinals | https://www.traditionalmedicinals.com/ | Huifen | He | Director of R&D | https://www.linkedin.com/in/huifen-he-1659a68b/ | huifen.he@corbion.com | NALTYX |
32 | 29 | Lin BioScience | https://www.linbioscience.com/ | Irene | Wang | R&D Director | https://www.linkedin.com/in/irenewangphdmba/ | irenewang@belitebio.com | NALTYX |
33 | 30 | Inovio Pharmaceuticals Inc. | https://www.inovio.com/ | Trevor | Smith | Director, R&D | https://www.linkedin.com/in/trevor-smith-1325913/ | tsmith@inovio.com | NALTYX |
34 | 31 | Hello Products LLC | https://www.hello-products.com/ | Connie | Gregson | Director, R&D | https://www.linkedin.com/in/connie-gregson-5090855/ | connie@hello-products.com | NALTYX |
35 | 32 | Theranova, LLC | https://www.theranova.com/ | Bryan | Nowroozi | Director of R&D | https://www.linkedin.com/in/bryannowroozi/ | bryan@mimeolabs.com | NALTYX |
36 | 33 | Pall Corporation | https://www.pall.com/ | Scott | Gordon | R&D | https://www.linkedin.com/in/scott-gordon-878498a/ | scott.gordon@hitchcock.org | NALTYX |
37 | 34 | Alexion Pharmaceuticals, Inc. | https://alexion.com/ | Rui-Ru | Ji | Director, R&D | https://www.linkedin.com/in/rui-ru-ji-a516391/ | rui-ru.ji@alexion.com | NALTYX |
38 | 35 | NICE Actimize | https://www.niceactimize.com/ | Roman | Kapelman | R&D | https://www.linkedin.com/in/roman-kapelman-50b9093/ | rkapelman@niceactimize.com | NALTYX |
39 | 36 | Boston Scientific | https://www.bostonscientific.com/en-US/Home.html | Chris | Oskin | R&D Director | https://www.linkedin.com/in/chris-oskin-6b73947/ | oskinc@bsci.com | NALTYX |
40 | 37 | Generational Equity, LLC | https://www.genequityco.com/ | David | Fergusson | Executive Managing Director - M&A | https://www.linkedin.com/in/davidafergusson | dfergusson@generational.com | NALTYX |
41 | 38 | Deloitte | https://www2.deloitte.com/us/en.html | Anthony | Passalaqua | M&A | https://www.linkedin.com/in/anthony-passalaqua-89060831 | apassalaqua@deloitte.com | NALTYX |
42 | 39 | Cummins Inc. | https://www.cummins.com/ | Can | Okandan | Director - M&A Integration | https://www.linkedin.com/in/canokandan/ | can.okandan@cummins.com | NALTYX |
43 | 40 | Rotork | https://www.rotork.com/en | Vijay | Rao | Group Strategy and M&A Director | https://www.linkedin.com/in/vijayrao | vijay.rao@rotork.com | NALTYX |
44 | 41 | Potomac Business Capital | http://potomacbusinesscapital.com/ | Brandon | Miller | M&A Director | https://www.linkedin.com/in/brandon-miller-04082112/ | brandon@potomacbusinesscapital.com | NALTYX |
45 | 42 | JAB Holding Company LLC | https://www.jabholco.com/ | David | Bell | Partner, Head of M&A | https://www.linkedin.com/in/david-bell-38305a17 | david.bell@jabholco.com | NALTYX |
46 | 43 | HighTower | https://hightoweraccess.com/ | Marc | Cabezas | Executive Director, Head of M&A | https://www.linkedin.com/in/marccabezas | mark@hightoweraccess.com | NALTYX |
47 | 44 | Quidel | https://www.quidel.com/ | Steven | Hoyt | Senior Director - M&A | https://www.linkedin.com/in/hoytsj/ | shoyt@quidel.com | NALTYX |
48 | 45 | Stryker | https://www.stryker.com/ | Billy | Singleton | Sr Director Supply Chain M&A and Planning | https://www.linkedin.com/in/singleton | billy.singleton@stryker.com | NALTYX |
49 | 46 | Arbor Ridge Partners | https://www.arborridgepartners.com/ | George | Tziahanas | Advisor, M&A | https://www.linkedin.com/in/georgetziahanas | george.tziahanas@arborridgepartners.com | NALTYX |
50 | 47 | LogMeIn | https://www.logmein.com/ | Anna | Khromey | Director, Corporate Development (M&A and Strategy) | https://www.linkedin.com/in/annakhromey | anna.khromey@logmein.com | NALTYX |
51 | 48 | Sheridan Healthcorp | http://sheridanhealthcare.com/ | Robb | Doom | IT M&A | https://www.linkedin.com/in/robbdoom | robb.doom@shcr.com | NALTYX |
52 | 49 | VonLehman & Company Inc. | https://vlcpa.com/ | Keith | Carlson | Managing Director - M&A Advisory | https://www.linkedin.com/in/keithcarlson83 | kcarlson@vlcpa.com | NALTYX |
53 | 50 | ABB | https://new.abb.com/ | David | Keating | Vice President, Head of Business Development and M&A Americas | https://www.linkedin.com/in/david-keating-032bb01 | david.keating@abb.com | NALTYX |
54 | 51 | Trinity Health (HQ Michigan) | http://www.trinity-health.org/ | Melissa | Fury | Vice President M&A Integration and Operational Alignment | https://www.linkedin.com/in/melissa-fury-fache-3346688 | melissa.fury@trinity-health.org | NALTYX |
55 | 52 | DaVita Kidney Care | https://www.davita.com/ | Tiffany | Bishop | Director Of Benefits/M&A | https://www.linkedin.com/in/tiffany-bishop-phr-6514b4b | tiffany.bishop@davita.com | NALTYX |
56 | 53 | KLA-Tencor | https://www.kla-tencor.com/ | Danny | Van | Director of M&A and Integration | https://www.linkedin.com/in/danny-van-7279881/ | danny.van@kla-tencor.com | NALTYX |
57 | 54 | WEX | https://www.wexinc.com/ | Lisa | O'Brien | Director, M&A Integration | https://www.linkedin.com/in/lisa-green-o-brien-a0701510/ | lisa.obrien@wexinc.com | NALTYX |
58 | 55 | TransDigm Group Inc. | https://www.transdigm.com/ | Jamison | M. | Director, M&A | https://www.linkedin.com/in/jamison-m-18996815/ | jmclaughlin@transdigm.com | NALTYX |
59 | 56 | DaVita Inc. | https://www.davita.com/ | Phillip | Park | Director - M&A | https://www.linkedin.com/in/phillippark/ | phillip.park@davita.com | NALTYX |
60 | 57 | Exela Technologies | https://www.exelatech.com/ | Jeremiah | Hennessy | Vice President - M&A and Integration | https://www.linkedin.com/in/jeremiah-hennessy-635a274 | jhennessy@exelatech.com | NALTYX |
61 | 58 | Samsung NEXT | https://samsungnext.com/ | Raghu | Mittal | Director, M&A | https://www.linkedin.com/in/mittalraghu | raghu.mittal@samsungnext.com | NALTYX |
62 | 59 | The Scotts Miracle-Gro Company | https://scottsmiraclegro.com/ | David | Aronowitz | Head of M&A | https://www.linkedin.com/in/davearonowitz | david.aronowitz@scotts.com | NALTYX |
63 | 60 | Lumeon | https://www.lumeon.com/ | Andrew | Watson | General Counsel & Head of IP | https://www.linkedin.com/in/andrewwatson3?originalSubdomain=uk | andrew.watson@lumeon.com | NALTYX |
64 | 61 | Helvetas | https://www.helvetas.org/en/switzerland | Remo | Gesu | Head IP | https://ch.linkedin.com/in/remo-gesu-714ab317 | remo.gesu@helvetas.org | NALTYX |
65 | 62 | Atos | https://atos.net/en/ | Yann | Dietrich | Head of IP Strategy & Development | https://www.linkedin.com/in/yanndietrich/?originalSubdomain=fr | yann.dietrich@atos.net | NALTYX |
66 | 63 | Oxford Nanopore Technologies Ltd. | https://nanoporetech.com/ | Martyn | Andrews | Head of IP | https://www.linkedin.com/in/martyn-andrews-4ab3027/?originalSubdomain=uk | martyn.andrews@nanoporetech.com | NALTYX |
67 | 64 | Cell and Gene Therapy Catapult | https://ct.catapult.org.uk/ | Jodie | Albutt | Head of IP | https://www.linkedin.com/in/jodie-albutt-22274167/?originalSubdomain=uk | jodie.albutt@ct.catapult.org.uk | NALTYX |
68 | 65 | SOTIO | https://www.sotio.com/ | Christoph | Rehfuess | Head of IP | https://www.linkedin.com/in/christoph-rehfuess-80114518/?originalSubdomain=de | rehfuess@sotio.com | NALTYX |
69 | 66 | Xaar | https://www.xaar.com/en/ | Gavin | Clarke | Head of IP and Legal | https://www.linkedin.com/in/gavin-clarke-86332a/?originalSubdomain=uk | gavin.clarke@xaar.com | NALTYX |
70 | 67 | Naspers Group | https://www.naspers.com/ | Shailendra | Bhumralkar | Global Head of IP | https://www.linkedin.com/in/sbhumralkar/?originalSubdomain=nl | sbhumralkar@naspers.com | NALTYX |
71 | 68 | Novartis Pharma AG | https://www.novartis.com/ | Ian | Hiscock | Head IP Oncology | https://www.linkedin.com/in/ian-hiscock-21796924/?originalSubdomain=ch | ian_james.hiscock@novartis.com | NALTYX |
72 | 69 | Kamstrup | https://www.kamstrup.com/en-en | Rasmus | Dupont | Head of IP | https://dk.linkedin.com/in/rasmusdupont | rsd@kamstrup.com | NALTYX |
73 | 70 | Oxford BioMedica | https://www.oxb.com/ | Kati | Hudson | Head of IP and Contracts | https://www.linkedin.com/in/kati-hudson-37828b49/?originalSubdomain=uk | k.hudson@oxfordbiomedica.co.uk | NALTYX |
74 | 71 | Adaptimmune Ltd | https://www.adaptimmune.com/ | Norman | Law | Head of IP | https://www.linkedin.com/in/normanlaw/?originalSubdomain=uk | norman.law@adaptimmune.com | NALTYX |
75 | 72 | Soitec | https://www.soitec.com/en | William | Nivol | Head of IP | https://www.linkedin.com/in/william-nivol-65962726/?originalSubdomain=fr | william.nivol@soitec.com | NALTYX |
76 | 73 | Mishcon de Reya LLP | https://www.mishcon.com/ | Jeremy | Hertzog | Partner, Head of IP | https://www.linkedin.com/in/jeremy-hertzog-65080110/?originalSubdomain=uk | jeremy.hertzog@mishcon.com | NALTYX |
77 | 74 | Uriach | http://www.uriach.com/ | Florian | Michalek | Head IP | https://www.linkedin.com/in/florian-michalek-a1726817/?originalSubdomain=es | florian.michalek@uriach.com | NALTYX |